Market Access News | pharmaphorum

News

FDA clears Gamida’s cord blood therapy for cancer patients

The FDA has approved a stem cell-based therapy for cancer patients from Israeli biotech Gamida Cell that is designed to help them recover more quickly from aggressive chem

News

SCOTUS blocks restrictions on abortion pill mifepristone

In the latest twist and turn of the rancorous abortion pill battle in the US, the Supreme Court has temporarily halted a lower court ruling that would have restricted acce

News

FDA rejects Teva’s high-potency biosimilar of Humira again

Teva and partner Alvotech’s hopes of launching their biosimilar of AbbVie’s high-potency formulation of big-selling immunology drug Humira have been dashed, after the FDA

News

FDA won’t approve Lilly’s mirikizumab for ulcerative colitis

The FDA has issued a complete response letter to Eli Lilly, turning down its attempt to get approval for anti-IL-23p19 antibody mirikizumab as a treatment for ulcerative c

News

Ghana first country to approve Oxford malaria vaccine

A malaria vaccine developed by members of the University of Oxford team that created the AstraZeneca COVID-19 jab has been approved in its first market, Ghana.

News

ICER backs sickle cell gene therapies at one-off cost of $2m

The influential Institute for Clinical and Economic Review (ICER) in the US has issued draft guidance suggesting that new gene therapies for sickle cell disease (SCD) from

FDA clears Gamida’s cord blood therapy for cancer patients

SCOTUS blocks restrictions on abortion pill mifepristone

FDA rejects Teva’s high-potency biosimilar of Humira again

FDA won’t approve Lilly’s mirikizumab for ulcerative colitis

Ghana first country to approve Oxford malaria vaccine

ICER backs sickle cell gene therapies at one-off cost of $2m

EU first to clear AbbVie's Rinvoq for alopecia areata

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks